Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Novartis says operating profit to grow again in 2023

Published by Uma Rajagopal

Posted on February 1, 2023

1 min read

· Last updated: February 2, 2026

Add as preferred source on Google

The image features the Novartis logo prominently displayed at a new factory in Stein, illustrating the company's optimism for mid-single-digit growth in operating profit in 2023, as discussed in the article.

innovation financial community corporate profits

Global Banking & Finance Awards 2026 — Call for Entries

By Ludwig Burger BASEL (Reuters) -Swiss drugmaker Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023, following stagnation last year. Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion. Adjusted […]

By Ludwig Burger

BASEL (Reuters) -Swiss drugmaker Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023, following stagnation last year.

Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion.

Adjusted for overall negative currency effects, group sales in 2022 advanced 4% to $50.5 billion as gains from heart failure drug Entresto and multiple sclerosis (MS) drug Kesimpta were partly offset by competition from cheap generic copies of established MS drug Gilenya.

(Reporting by Ludwig BurgerEditing by Paul Carrel)

Frequently Asked Questions

What is operating profit?

Operating profit is the income earned from a company's core business operations, excluding deductions of interest and taxes. It reflects the efficiency of the company's operations.

What is core operating income?

Core operating income refers to the profit a company makes from its regular business activities, excluding any income from non-operating activities or one-time events.

What are generic drugs?

Generic drugs are medications that are equivalent to brand-name drugs in dosage form, strength, route of administration, quality, and performance characteristics, but are marketed without brand names.

What is currency effect?

Currency effect refers to the impact that fluctuations in exchange rates have on the value of a company's foreign earnings when converted back to its home currency.

What is market expectation?

Market expectation is the anticipated performance or outcome of a company or market based on current information, trends, and economic indicators.

Novartis says operating profit to grow again in 2023

Frequently Asked Questions

Tags

Related Articles

Why Curiosity Is the Hidden Engine Behind Every Big Idea

The Silent Shift Reshaping Global Finance

The Invisible Forces Rewiring Global Finance—And Why the Shift Is Already Underway

The Global Finance Reset No One Is Talking About—But Everyone Is Feeling

The Financial Trend Hiding in Plain Sight—Why Everything Feels the Same, But Isn’t

The Financial System’s New Rhythm—Why Change Is Happening Without Disruption

More from Top Stories